PARENTERALE NOROVIRUS-IMPFSTOFFFORMULIERUNGEN

Patent europeic · EP2731621 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2731621
Numer da la dumonda
EP12811916
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-07-2012
Publitgà
21-05-2014
Concedì
01-11-2017
La protecziun finescha il pli tard
10-07-2032
Proxima taxa annuala scadenta
31-07-2026
Classas IPC
A61K 39/125 (2006.01)
Prioritad
US 201161506447 P 11.07.2011
Dumonda PCT
PCT/US2012/046222 11.07.2012
Publicaziun PCT
WO2013/009849 17.01.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2025

    Midada

    Published in Swissreg on 01.08.2025

  2. 01-08-2024

    Midada

    Published in Swissreg on 01.08.2024

  3. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  4. 01-08-2022

    Midada

    Published in Swissreg on 01.08.2022

  5. 22-09-2021

    Transferì

    Owner
    Takeda Vaccines, Inc., 2155 Analysis Drive, Bozeman, MT 59718, USA → Takeda Vaccines, Inc., 75 Sidney Street, Cambridge, MA 02139, USA

    Published in Swissreg on 22.09.2021

  6. 01-11-2017

    Concedì

    Published in Swissreg on 01.11.2017

Partidas

Inventur

RICHARDSON, Charles

Bozeman, Montana 59718, US

BARGATZE, Robert, F.

Bozeman, Montana 59718, US

MENDELMAN, Paul, M.

Bozeman, Montana 59718, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.